DMI-Logo
search-iconsearch-icon

Others Research Reports & Consulting

Home
>
Reports
>
Pharmaceuticals
>
Others
Browse reports
DataM has exclusive market relevance and knowledge catering our services in 60+ industries
SUB CATEGORIES
All PharmaceuticalsCardiovascularCentral Nervous SystemDermatologyEar Nose Throat DisordersGastrointestinalGenitourinary DisordersHematologyHormonal DisordersImmunologyInfectious DiseaseMetabolic DisorderDiabetes CareMouth And Dental DisordersPain ManagementMusculoskeletalNeurologyNon-Malignant DisordersNutritional DisordersOncologyOphthalmologyOther DiseasesAllergyRespiratoryWomen's and Male HealthWound Care TreatmentSyndromeOthers
FILTER
Geography
Publish Date
Themesdown
SORT
Upload Date
Upload Date
Price
Published: 2025 April 25
Latin America Pain Management Drugs Market Size, Share Analysis, Growth Insights and Forecast 2025-2033
Latin America pain management drugs market reached US$ 4,069.52 million in 2024 and is expected to reach US$ 6,576.78 million by 2033
Starting from
$3750$3000
Published: 2025 April 25
North America Pain Management Market Size, Share Analysis, Growth Insights and Forecast 2025-2033
North America Pain Management Market reached US$ 25.85 billion in 2024 and is expected to reach US$ 46.87 billion by 2033
Starting from
$3750$3000
Published: 2025 July 03
Global Lymphedema Market Size, Share Analysis, Growth Insights and Forecast 2025-2033
According to DMI Analysis, lymphedema market reached US$ 989.85 million in 2024 and is expected to reach US$ 2,029.90 million by 2033
Starting from
$4350$3480
Published: 2025 July 04
Acute Myocardial Infarction Market Size, Share Analysis, Growth Insights and Forecast 2025-2033
According to DMI Analysis, Acute Myocardial Infarction Market reached US$ 1,790.79 million in 2024 and is expected to reach US$ 3,065.81 million by 2033
Starting from
$4350$3480
Published: 2026 April 08
US Biosimilars Market 2025-2033
US Biosimilars Market size reached US$ 8.62 billion in 2024 and is expected to reach US$ 65.62 billion by 2033
Starting from
$3175$2540
Published: 2026 May 15
Cystic Fibrosis Pipeline Insights 2025
Cystic Fibrosis Pipeline Insights 2026 offers comprehensive analysis of emerging therapies, late-stage clinical candidates, CFTR modulators, gene and mRNA-based treatments, key biotech innovations, regulatory developments, and competitive landscape shaping the future of cystic fibrosis treatment worldwide.
Starting from
$4350$3480
Published: 2026 May 27
Global Vascular Endothelial Growth Factor Receptor (VEGFR) Inhibitors Market - Size, Share, and Forecast 2026-2033
Vascular Endothelial Growth Factor Receptor (VEGFR) Inhibitors Market reached US$ 14.13 billion in 2025 and is expected to reach US$ 22.34 billion by 2033
Starting from
$4350$3480
Published: 2026 May 22
Antisense Oligonucleotides Market Size, Share Analysis, Growth Insights and Forecast 2026-2033
The Global Antisense Oligonucleotides Market reached US$ 3,180.1 million in 2024 and is expected to reach US$ 5,286.96 million by 2033
Starting from
$4350$3480
Published: 2026 July 06
Metabolic Dysfunction-Associated Steatohepatitis (MASH) Market - Epidemiology Insights 2035
The Metabolic Dysfunction-Associated Steatohepatitis Market is expected to reach at a CAGR of 17.55% during the forecast period 2026-2035.
Starting from
$4350$3480
Published: 2026 January 05
Gastroparesis Treatment Market Size, Share, and Forecast (2025-2033)
Gastroparesis treatment market reached US$ 7.5 billion in 2024 and is expected to reach US$ 11.03 billion by 2033, growing at a CAGR of 4.42% during 2025–2033.
Starting from
$4350$3480